AxoGen, Inc. Selected to Present at SEMDA 2014 Conference

[GlobeNewswire] – ALACHUA, Fla. — via PRWEB – AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion U.S. peripheral nerve repair market, announced today that it has been selected … more

View todays social media effects on AXGN

View the latest stocks trending across Twitter. Click to view dashboard

See who AxoGen is hiring next, click here to view